Reference
Jackson W, et al. Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review. Matern Health Neonatol Perinatol. 2018;4:23. https://doi.org/10.1186/s40748-018-0092-2.
Maternal Health, Neonatology and Perinatology volume 5, Article number: 13 (2019)
Correction to: Matern Health Neonatol Perinatol (2018) 4:23
https://doi.org/10.1186/s40748-018-0092-2
Following publication of the original article [1], the authors notified us that they would like to acknowledge Anjali Gupta for her contribution to the background for this systematic review.
Jackson W, et al. Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review. Matern Health Neonatol Perinatol. 2018;4:23. https://doi.org/10.1186/s40748-018-0092-2.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jackson, W., Taylor, G., Selewski, D. et al. Correction to: Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review. matern health, neonatol and perinatol 5, 13 (2019). https://doi.org/10.1186/s40748-019-0108-6
Published:
DOI: https://doi.org/10.1186/s40748-019-0108-6